To encourage the research and development (R&D) of innovative medical devices and improve the quality of clinical trial for advanced medical devices in Taiwan, the Taiwan Food and Drug Administration (TFDA) will hold the “2017 Innovative Medical Device Regulatory Science Symposium” at the National Taiwan University Hospital International Conference Center on September, 20th and 21st, 2017.
The topics of the Symposium will be focused on three most pioneering categories of devices: combination products, active implantable medical devices, and exoskeleton robot devices. With an esteemed gathering of regulatory experts from Europe, the U.S., Japan, China and Taiwan, the Symposium will feature a high-level exchange of information and experiences on the clinical trial and premarket registration for innovative medical devices. In order to protect people’s health and safety, the R&D of such devices must comply with the requirements of related international standards and regional regulations. Through the discussions among global regulatory experts, attendees will receive an in-depth understanding of the regulatory science of innovative medical devices.
The Symposium is looking forward to bringing together of passionate and creative participants from industries, official, hospitals, academic and research institutes. The Symposium will benefit the development and time-to-market of innovative medical devices in Taiwan.